SR One

SR One related stories

All articles and analysis

• 
  Novalar Raises $30 Million

  PE Hub Staff- 1 November 2007
• 
  Syntaxin Raises Second Round

  PE Hub Staff- 1 November 2007
• 
  Phase Bioscience Adds $5.4 Million

  PE Hub Staff- 25 October 2007
• 
  VCs float cancer specialist

  Brad Meikle- 1 May 2007

  Norway’s Algeta make Oslo debut

• 
  VC life sciences and biotech

  Brad Meikle- 1 February 2007

  About US$80bn worth of pharmaceutical sales will face patent expiration by 2009 forcing the pharmaceutical giants to feed their hungry product pipelines as drugs go generic. This would seem to be good news for biotech and biopharmaceutical companies, but in practice it is becoming more challenging than ever to succeed.

• 
  Rawcliffe Takes On Larger Role with GSK

  Brad Meikle- 20 December 2006
• 
  PE Week Wire, Dec. 20, 2006

  Brad Meikle- 20 December 2006

  Random Ramblings

• 
  PE Week Wire, Dec. 20, 2006

  Brad Meikle- 20 December 2006

  Random Ramblings

• 
  PE Week Wire, Dec. 20, 2006

  Brad Meikle- 20 December 2006

  Random Ramblings

• 
  PE Week Wire, Dec. 20, 2006

  Brad Meikle- 20 December 2006

  Random Ramblings